HIGH GRADE GLIOMAS
Clinical trials for HIGH GRADE GLIOMAS explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE GLIOMAS trials appear
Sign up with your email to follow new studies for HIGH GRADE GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New brain cancer strategy: chemo first, radiation later
Disease control Not yet recruitingThis study is testing a new treatment order for aggressive brain tumors called high-grade gliomas. Researchers want to see if giving the chemotherapy drug temozolomide before standard radiation therapy is safe and effective. They believe this approach might make post-treatment MR…
Matched conditions: HIGH GRADE GLIOMAS
Phase: PHASE2 • Sponsor: The Cooper Health System • Aim: Disease control
Last updated Apr 04, 2026 04:35 UTC
-
New gene therapy aims to turn the body against deadly brain cancer
Disease control Not yet recruitingThis study is testing a new gene therapy called TGX-007 for people with a fast-growing type of brain cancer called glioblastoma. The therapy uses a harmless virus to deliver two treatments directly into the tumor: one to kill cancer cells and another to activate the patient's own…
Matched conditions: HIGH GRADE GLIOMAS
Phase: PHASE1, PHASE2 • Sponsor: Trogenix ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with rare, aggressive brain cancers in early drug trial
Disease control Not yet recruitingThis is a first-in-children study to find a safe dose of an experimental oral drug called gallium maltolate for kids whose aggressive brain tumors have returned or not responded to standard treatments. The main goal is to understand the drug's side effects and how the body proces…
Matched conditions: HIGH GRADE GLIOMAS
Phase: PHASE1 • Sponsor: Sarah Rumler • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Glowing drug lights up deadly brain tumors for surgeons
Knowledge-focused Not yet recruitingThis early study is testing a new version of a cancer drug (nivolumab) that has been made to glow. The goal is to see if this glowing drug can safely help surgeons better see and map out aggressive brain tumors during surgery. The study will involve 38 adults with high-grade glio…
Matched conditions: HIGH GRADE GLIOMAS
Phase: EARLY_PHASE1 • Sponsor: Eben Rosenthal • Aim: Knowledge-focused
Last updated Apr 04, 2026 04:36 UTC